Clinical Study

Long Term Safety Study Of Amifampridine Phosphate In Patients With Musk Antibody Positive And Achr Antibody Positive Myasthenia Gravis Patients

Posted Date: May 15, 2019

  • Investigator: Hani Kushlaf
  • Specialties:
  • Type of Study: Drug

MuSK (MSK-003 OL)

Criteria:

? Must Be At Least 18 Years Of Age ? Must Have Participated In A Previous Study With The Study Med

Keywords:

Achr Antibody Positi, Musk Antibody Positi, Myasthenia Gravis

For More Information:

Molly Winters
513-558-0269
molly.winters@uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.